Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kelsey, Linda ^a   Katoch, Parul ^a   Johnson, Kristen E ^a   Batra, Surinder K ^a   Mehta, Parmender P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANDROGEN; ANDROGEN RECEPTOR; CONNEXIN 32; RETINOIC ACID; GAP JUNCTION PROTEIN; RETINOID;

ARTICLE; CANCER CELL; CELL COMMUNICATION; CELL GROWTH; CELL STRAIN LNCAP; COLONY FORMATION; CONTROLLED STUDY; DEGRADATION; GAP JUNCTION; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL JUNCTION; DRUG EFFECT; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ANDROGENS; CELL LINE, TUMOR; CONNEXINS; GAP JUNCTIONS; HUMANS; MALE; PROSTATIC NEOPLASMS; RETINOIDS; TRETINOIN;

EID: 84859741577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032846     Document Type: Article

References (85)

1. Duester G, (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134: 921-931.
2. Clagett-Dame M, DeLuca H, (2002) The role of vitamin A in mammalian reproduction and embryonic development. Ann Rev Nutr 22: 347-381.
3. Aranda A, Pascual A, (2001) Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304.
4. Pfahl M, Chytil F, (1996) Regulation of metabolism by retinoic acid and its nuclear receptors. Ann Rev Nutr 16: 257-283.
5. Ross S, McCaffery P, Drager U, de Luca L, (2000) Retinoids in embryonal development. Physiol Rev 80: 1021-1054.
6. Goodenough DA, Goliger JA, Paul DA, (1996) Connexins, connexons, and intercellular communication. Annual Review of Biochemistry 65: 475-502.
7. Trosko J, Chang C-C, (2001) Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat Res 480: 219-229.
8. Wei CJ, Xu X, Lo CW, (2004) Connexins and cell signaling in development and disease. Ann Rev Cell Dev Biol 20: 811-838.
9. Beyer EC, Berthoud VM, (2009) The Family of Connexin Genes. In: Harris A, Locke D, editors. Connexins: A Guide Springer pp. 3-26.
10. Laird DW, (2006) Life cycle of connexins in health and disease. Biochem J 394: 527-543.
11. Laird DW, (2010) The gap junction proteome and its relationship to disease. Trends Cell Biol 20: 92-101.
12. Naus CC, Laird DW, (2010) Implications and challenges of connexin connections to cancer. Nat Rev Cancer 10: 435-441.
13. Habermann H, Chang WY, Birch L, Mehta P, Prins GS, (2001) Developmental Exposure to Estrogens Alters Epithelial Cell Adhesion and Gap Junction Proteins in the Adult Rat Prostate. Endocrinology 142: 359-369.
14. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, et al. (1999) Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genetics 24: 91-110.
15. Habermann H, Ray V, Prins G, (2002) Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J Urol 167: 655-660.
16. Govindarajan R, Song X-H, Guo R-J, Wheelock MJ, Johnson KR, et al. (2002) Impaired traffcking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by a-catenin. J Biol Chem 277: 50087-50097.
17. Mitra S, Annamalai L, Chakraborty S, Johnson K, Song X, et al. (2006) Androgen-regulated Formation and Degradation of Gap Junctions in Androgen-responsive Human Prostate Cancer Cells. Mol Biol Cell 17: 5400-5416.
18. Marker P, Donjacour A, Dahiya R, Cunha G, (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253: 165-174.
19. Shen MM, Abate-Shen C, (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes & Development 24: 1967-2000.
20. Wilson J, Roth C, Warkany J, (1953) An analysis of the syndrome of malformations induced by maternal vitam A deficeincy. Effects of restoriation of vitamin A at varruous times during gestation. Am J Anat 92: 189-217.
21. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, et al. (1993) Function of retinoic acid receptor gamma in the mouse. Cell 73: 643-658.
22. Huang J, Powell W, Khodavirdi A, Wu J, Makita T, et al. (2002) Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 62: 4812-4819.
23. Altucci L, Gronemeyer H, (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1: 181-193.
24. Sporn MB, (2002) Chemoprevention: an essential approach in preventing cancer. Nat Rev Cancer 2: 537-543.
25. Bertram J, (1999) Carotenoids and Gene Regulation. Nutr Rev 57: 182-191.
26. Mehta P, Bertram J, Loewenstein W, (1989) The actions of retinoids on cellular growth correlate with their actions on gap junctional communication. J Cell Biol 108: 1053-1065.
27. Mehta P, Loewenstein W, (1991) Differential regulation of communication by retinoic acid in homologous and heterologous junctions between normal and transformed cells. J Cell Biol 113: 371-379.
28. Trosko J, (2007) Gap Junctional Intercellular Communication as a Biological "Rosetta Stone" in Understanding, in a Systems Biological Manner, Stem Cell Behavior, Mechanisms of Epigenetic Toxicology, Chemoprevention and Chemotherapy. J Memb Biol 218: 93-100.
29. Kojima T, Murata M, Go M, Spray DC, Sawada N, (2007) Connexins induce and maintain tight junctions in epithelial cells. J Membr Biol 217: 13-19.
30. Zhao X, Ly L, Peehl D, Feldman D, (1999) Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology 140: 1205-1212.
31. Igawa T, Lin FF, Lee MS, Karan D, Batra SK, et al. (2002) Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate 50: 222-235.
32. Chakraborty S, Mitra S, Falk MM, Caplan S, Wheelock MJ, et al. (2010) E-cadherin differentially regulates the assembly of connexin43 and connexin32 into gap junctions in human squamous carcinoma cells. J Biol Chem 285: 10761-10776.
33. Govindarajan R, Chakraborty S, Falk MM, Johnson KR, Wheelock MJ, et al. (2010) Assembly of connexin43 is differentially regulated by E-cadherin and N-cadherin in rat liver epithelial cells. Mol Biol Cell 21: 4089-4107.
34. Mehta P, Bertram J, Loewenstein W, (1986) Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44: 187-196.
35. VanSlyke JK, Musil LS, (2000) Analysis of connexin intracellular transport and assembly. Methods 20: 156-164.
36. Jongen WM, Fitzgerald DJ, Asamoto M, Piccoli C, Slaga TJ, et al. (1991) Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol 114: 545-555.
37. Meyer R, Laird D, Revel J-P, Johnson R, (1992) Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol 119: 179-189.
38. Kojima T, Kokai Y, Chiba H, Yamamoto M, Mochizuki Y, et al. (2001) Cx32 but Not Cx26 Is Associated with Tight Junctions in Primary Cultures of Rat Hepatocytes. Experimental Cell Research 263: 193-201.
39. Kojima T, Spray DC, Kokai Y, Chiba H, Mochizuki Y, et al. (2002) Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line. Exp Cell Res 276: 40-51.
40. Kemppainen J, Wilson J, (1996) Agonist and antigonis activities of hydroxyfluamide and casodex relat to androgen receptor stabilization. Urology 48: 157-163.
41. Farla P, Hersmus R, Trapman J, Houtsmuller AB, (2005) Antiandrogens prevent stable DNA-binding of the androgen receptor. Journal of Cell Science 118: 4187-4198.
42. Lasnitzki I, Goodman D, (1974) Inhibition of the effects of methylcholanthrene on mouse prostate in organ culture by vitamin A and its analogs. Cancer Res 34: 1564-1571.
43. Lasnitzki I, Whitaker R, Withcombe J, (1975) The effect steroid hormones on the growth pattern and RNA synthesis in human benign prostatic hyperplasia in organ culture. Br J Cancer 32: 168-178.
44. Manual M, Ghyselink NB, Chambon P, (2006) Functions of the retinoid nuclear receptors: Lessons from the genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embyrogenesis. Ann Rev Pharm Tox 46: 451-480.
45. Vezina C, Allgeier SMT, Fritz W, Moore R, Strerath M, et al. (2008) Retinoic acid induces prostatic bud formation. Dev Dyn 237: 1321-1333.
46. Perissi V, Rosenfeld MG, (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6: 542-554.
47. Bavamian S, Klee P, Allagnat F, Haefliger J-A, Meda P, (2009) Connexins and secretion. In: Harris A, Locke D, editors. Connexins: A Guide Springer pp. 511-528.
48. Derynck R, Yancey S, Traub O, Willecke K, Revel J-P, (1987) Major loss of the 28-KD protein of gap junction in proliferating hepatocytes. J Cell Biol 105: 1925-1934.
49. Habermann H, Ray V, Habermann W, Prins GS, (2001) Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J Urol 166: 2267-2272.
50. Kojima T, Sawada N, Oyamada M, Chiba H, Isomura H, et al. (1994) Rapid appearance of connexin 26-positive gap junctions in centrilobular hepatocytes without induction of mRNA and protein synthesis in isolated perfused liver of female rat. J Cell Sci 107 (Pt 12): 3579-3590.
51. Kojima T, Mitaka T, Paul DL, Mori M, Mochizuki Y, (1995) Reappearance and long-term maintenance of connexin32 in proliferated adult rat hepatocytes: use of serum-free L-15 medium supplemented with EGF and DMSO. J Cell Sci 108: 1347-1357.
52. Kokai Y, Murata M, Go M, Spray DC, Sawada N, (2011) Connexins induce and maintain tight junctions in epithelial cells. J Membr Biol 217: 13-19.
53. Cunha G, Donjacour A, Cooke P, Mee S, Bigsby R, et al. (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8: 338-362.
54. Lasnitzki I, (1976) Reversal of methylchoantherene-induced changes in mouse prostates in vitro by retinoic acid and its analogues. British Journal of Cancer 34: 239-248.
55. Christov KT, Moon RC, Lantvit DD, Boone CW, Steele VE, et al. (2002) 9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats. Cancer Res 62: 5178-5182.
56. Zhang X, (2002) Vitamin A and apoptosis in prostate cancer. Endocr Relat Cancer 9: 87-102.
57. King TJ, Bertram JS, (2005) Connexins as targets for cancer chemoprevention and chemotherapy. Biochimica et Biophysica Acta (BBA)- Biomembranes 1719: 146-160.
58. Trosko J, (2006) Dietary modulation of the multistage, multimechanisms of human carcinogenesis: effects on initiated stem cells and cell-cell communication. Nutr Cancer 94: 102-110.
59. Trosko J, (2006) From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Ann NY Acad Sci 1089: 36-58.
60. King TJ, Lampe PD, (2004) Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 25: 669-680.
61. King TJ, Lampe PD, (2004) The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor. Cancer Res 64: 7191-7196.
62. Temme A, Buchmann A, Gabriel H-D, Nelles E, Schwarz M, et al. (1997) High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin 32. Current Biology 7: 713-716.
63. Dehm SM, Tindall DJ, (2005) Regulation of androgen receptor signaling in prostate cancer. Expert Review of Anticancer Therapy 5: 63-74.
64. Iversen P, (2002) Antiandrogen monotherapy: indications and results. Urology 60: 64-71.
65. Hernandez-Blazquez F, Joazeiro P, Omori Y, Yamasaki H, (2001) Control of intracellular movement of connexins by E-cadherin in murine skin papilloma cells. Exp Cell Res 270: 235-247.
66. Blutt S, Allegretto EA, Pike JW, Weigel NL, (1997) 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocirnology 138: 1491-1497.
67. Esquenet M, Swinnen JV, Heyns W, Verhoeven G, (1996) Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1a, 25-dihydroxycholeccalciferol, all-trans retinoic acid, 9-Cis Retinoic acid, and phenylacetate. The Prostate 28: 182-194.
68. Fong C-J, Sutkowski DM, Braun EJ, Bauer KD, Sherwood ER, et al. (1993) Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells. The Journal of Urology 149: 1190-1194.
69. Kokontis JM, Hay N, Liao S, (1998) Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 12: 941-953.
70. Murthy S, Marcelli M, Weigel N, (2011) Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1a,25-Dihydroxyvitamin D3. The Prostate 56: 293-304.
71. Peehl D, Feldman D, (2003) The role of vitamin D and retinoids in controlling prostate cancer progression. Endocr Relat Cancer 10: 131-140.
72. Schuurmans A, Bolt J, Veldscholte J, Mulder E, (1991) Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Molec Biol 40: 193-197.
73. Umekita Y, Hiipakka RA, Kokontis JM, Liao S, (1996) Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation byáfinasteride. PNAS 93: 11802-11807.
74. Goodenough DA, Paul DL, (2009) Gap Junctions. Cold Spring Harbor Perspectives Biology 1: a002576.
75. Wang M, BERTHOUD VM, BEYER EC, (2007) Connexin43 increases the sensitivity of prostate cancer cells to TNF{alpha}-induced apoptosis. Journal of Cell Science 120: 320-329.
76. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, et al. (2007) The role of connexins in controlling cell growth and gene expression. Progress in Biophysics and Molecular Biology 94: 245-264.
77. McLachlan E, Shao Q, Wang Hl, Langlois S, Laird DW, (2006) Connexisn act as tumor suppressors in three dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 66: 9886-9894.
78. Feldman D, Zhao X-Y, Krishnan AV, (2000) Vitamin D and Prostate Cancer. Endocirnology 141: 5-9.
79. Altucci L, Gronemeyer H, (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1: 181-193.
80. Kolonel L, Hankin J, Yoshizawa C, (1987) Vitamin A and prostate cancer in elderly men: enhancement of risk. Cancer Res 47: 2982-2985.
81. Reichman M, Hayes R, Ziegler R, Schatzkin A, Taylor P, et al. (1990) Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res 50: 2311-2315.
82. Wilson JG, Roth CB, Warkany J, (1953) An analysis of the syndrome of malformations induced by maternal vitamin A deficeincy. Effects of restoriation of vitamin A at varruous times during gestation. Am J Anat 92: 189-217.
83. Albini A, Sporn MB, (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7.
84. Liby KT, Yore MM, Sporn MB, (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7: 357-369.
85. Sporn MB, (2002) Chemoprevention: an essential approach in preventing cancer. Nat Rev Cancer 2: 537-543.